Clinical Trial Update: Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial evaluating subcutaneous risankizumab for adults with moderate-to-severe plaque psoriasis involving the palms/soles; the study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Palmoplantar Psoriasis
• Plaque Psoriasis

Drugs mentioned

• SKYRIZI (risankizumab-rzaa)

Snippet

Sponsor: AbbVie | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2024-06-14